Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardioprotective effects of dexmedetomidine in patients with ischemic heart disease
PACTR201711002757295Unknown
- Sponsor
- doaa rashwan
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Trial of dexmedetomidine in coronary arteriosclerosis (2 arms), sponsored by doaa rashwan. Primary endpoint: Troponin I. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on PACTR201711002757295.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201711002757295.